Delivery Order SPE2DB22D2103-SPE2DB25FR9KD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,256.19 to AmerisourceBergen Drug Corp for the supply of Brimonidine-Timolol 0.2%-0.5% ophthalmic solution in a 10 milliliter formulation, with completion expected by August 29, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a delivery order valued at $4,237.09 to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (15mL) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a ceiling value of $1,217.05. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a contract ceiling value of $4,887.48. This is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,818.40 to AmerisourceBergen Drug Corp for the supply of Timolol 0.5% Gel-Solution 5mL, a topical ophthalmic medication commonly used to treat glaucoma and ocular hypertension. This firm fixed-price delivery order, issued on August 8, 2025, was competitively awarded with no set-aside designation and carries an ultimate completion date of August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 10 milliliters of Brimonidine Tartrate 0.15% ophthalmic drops, valued at $1,213.60, with a completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. As a delivery order, this award falls under a larger indefinite delivery contract (IDC) vehicle that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Timolol 0.5% gel-solution in 5ml units, with a ceiling value of $2,263.62 and a firm fixed price structure. This delivery order, which is not set-aside and represents a competitively awarded contract, will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 23, 2025. The contract is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Timolol 0.5% Gel-Solution 5ML, with a ceiling value of $3,427.07. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,773.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561935300 BRIMONIDINE-TIMOLOL 0.2%-0.5% 10ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is for the branded ophthalmic solution and runs from August 24 through August 25, 2023. As a top pharmaceutical supplier, Amerisourcebergen will deliver the requested medications to the DLA, the Department of...
- The Defense Logistics Agency awarded a $3,193.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (10mL) on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was fulfilled by AmerisourceBergen's Corporate Office division, with performance to be completed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9KDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Brimonidine-Timolol 0.2%-0.5% ophthalmic medication in a 10 mL formulation, with a ceiling value of $73,571.23. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 16, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing in federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a leading pharmaceutical distributor to federal healthcare systems, AmerisourceBergen supplies the Defense Health Agency, U.S. Coast Guard, and other government medical programs through this comprehensive global pharmaceutical support vehicle. The company's federal contracting portfolio demonstrates extensive experience delivering specialized medications across multiple therapeutic domains to support military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $73.6k | 6/13/25 |